je.st
news
Tag: data demonstrate
New KEYTRUDA (pembrolizumab) Data in Advanced Urothelial Cancer Demonstrate Overall Response Rate of 24 Percent in Cisplatin-Ineligible Patients
2016-10-08 08:15:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Results from Interim Analysis of Phase 2 KEYNOTE-052 Study to be Presented at ESMO 2016 Congress and Highlighted in ESMO Press Program First Presentation of Data Investigating KEYTRUDA in the Front Line Treatment of Bladder Cancer KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced positive findings from the phase 2 KEYNOTE-052 study investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in previously untreated patients with unresectable (inoperable) or metastatic urothelial cancer who are ineligible for cisplatin-based therapy. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orKim Hamilton, 908-740-1863orInvestors:Teri Loxam, 908-740-1986orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: data
advanced
rate
response
New Data Evaluating KEYTRUDA (pembrolizumab) in Combination with Chemotherapy for First-Line Treatment of Non-Small Cell Lung Cancer Demonstrate Response Rates Ranging from 48 to 71 Percent
2016-06-04 14:00:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Based on Initial Results Presented at 2016 ASCO Annual Meeting, Merck Has Initiated Two Phase 3 Studies KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced findings from an initial proof-of-concept study of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, combined with standard treatments, one with bevacizumab and others without, in non-small cell lung cancer (NSCLC) including chemotherapy in previously untreated patients with NSCLC; the study showed overall response rates (ORR) ranging from 48 to 71 percent, depending on the therapy used. Language: English Contact: MerckMedia Contacts:Pamela Eisele, (267) 305-3558orCourtney Ronaldo, (908) 236-1108orInvestor Contacts:Teri Loxam, (908) 740-1986orJustin Holko, (908) 740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
NASA engineers demonstrate wireless communication of aviation data to aircraft
2016-05-05 01:00:00| Airport Technology
Engineers from NASA's Glenn Research Centre have wirelessly transmitted aviation data to an aircraft on a runway at Cleveland Hopkins International Airport in Ohio, US.
Tags: data
communication
wireless
demonstrate
Westermo to Demonstrate Resilient Data Communications at RAIL2015
2015-09-04 15:51:00| Railway Technology
Westermo will bring its innovative and robust industrial data communications products alive at the RAIL2015 exhibition later this month. The company will have its Mobile Training and Technology Centre (MTTC) at the two-day event, enabling the company
Tags: data
communications
demonstrate
resilient
Samsung, SKT to demonstrate 7.5Gbps wireless data next week
2015-02-24 04:35:04| Wireless - Topix.net
Samsung Electronics and South Korean mobile operator SK Telecom plan to demonstrate next week research into future "5G" wireless and data transmission at 7.55Gbps. The two companies, which formed a research and development agreement on 5G wireless in October last year, will show off the technology at the Mobile World Congress expo in Barcelona.
Tags: data
week
wireless
samsung